endobj [0 /XYZ 69.5999999 The solution is indicated as a replacement therapy for conditions of deficiency or absence of endogenous testosterone Perrigo announced the launch of its Testosterone Topical Solution 30mg/1.5… endobj Testosterone Gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: • Primary hypogonadism (congenital... 2 DOSAGE AND ADMINISTRATION Dosage and Administration for Testosterone Gel, 1.62% differs from Testosterone Gel, 1%. �q0�@?b�c�i���T�Ũ'�A��+� `�}���ɡI@ 10 0 obj 1 0 obj << >> Please login or register first to view this content.Copyright © 2020 Haymarket Media, Inc. All Rights ReservedRegister now at no charge to access unlimited daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.Please login or register first to view this content. C I I I I n i t i a l U . endobj /MediaBox [0 0 612 792] /Producer (�� w k h t m l t o p d f) /PCSp 4 0 R [0 /XYZ 69.5999999 [0 /XYZ 56.1599999 endobj For more information, go to www.perrigo.com or call 1-866-634-9120 . 13 0 obj Testosterone Topical Solution will be available as a 30mg/1.5mL strength solution. [0 /XYZ 69.5999999 /XObject << (2.1) Apply to clean, dry intact skin of the axilla, not to any other parts of the body including the abdomen or genitals. endobj [0 /XYZ 56.1599999 Close more info about Perrigo Launches Generic Axiron Topical Solution 605.279999 0] >> >> Axiron Topical Solution is indicated as replacement therapy in males for conditions associated with deficiency or absence of endogenous testosterone, such as primary hypogonadism or hypogonadotropic hypogonadism (congenital or acquired). Perrigo introduces generic Axiron topical solution: Dublin Thursday, July 6, 2017, 16:00 Hrs [IST] Perrigo, a leading global healthcare company, announced the prescription pharmaceutical launch of testosterone topical solution, 30 mg/1.5 mL (CIII), the generic equivalent to Eli Lilly and Company's Axiron topical solution, 30 mg/1.5 mL (CIII). endobj /SM 0.02 T E S T O S T E R O N E t o p i c a l s o l u t i o n , f o r t o p i c a l u s e . endobj Close more info about Perrigo Launches Generic Axiron Topical Solution Close more info about Perrigo Launches Generic Axiron Topical Solution [ ] Endogenous Testosterone Topical Solution, a CIII controlled substance, is available as 30mg/1.5mL strength. /Annots 19 0 R [0 /XYZ 69.5999999 16 0 obj /ca 1.0 /ExtGState << /SMask /None>> %PDF-1.4 << /Type /ExtGState /Pattern << �8Զ�C�j�@[I�_����
@9�K���%M����b{�[q���T=���A`���/>Aׁ�2�P��_�Ry�pO��2g�AD�x�+�1��҉�6�Z4+h�6p(@���Ì����0Ư ����|�� W�%@��H��QIP /AIS false 14 0 obj >> 18 0 obj /Length 17 0 R << >> /CSpg /DeviceGray endobj 9 0 obj endobj Annual market sales for the 12 … 5 0 obj /Parent 2 0 R 12 0 obj 449.759999 0] A p p r o v a l : 1 9 5 3) /Font << �Oq��T0�{���U}�Ɲ�01R/�I�_�81� � ����v;�SzV��kn��V�jt�)�+fK��d]0,`���3�f����' S e e f u l l p r e s c r i b i n g i n f o r m a t i o n f o r T E S T O S T E R O N E T O P I C A L S O L U T I O N . 686.879999 0] /Resources 18 0 R endobj 64.7999999 0] 11 0 obj endobj /Type /Page x��]M��6����y���>����^ � ��� ���I`��zs��_u��G���#�KꞱb8c�E�^}�X|�χg������o���y����m���l��U���w��X�ᮬ������ͷ�����c����o�c��>�������{�S�֯����]ۙ�_���y��V�ʶ}+��{��Ϳ���1��㿸����|�8W5��ۿ&���h���!k�2��6�����p-�?��+����/�O?��� �"��]�!+ۖ�8�K;em��n�y��Ƥò��G�Er�E��v�bϒD��П) �G�,t$�~�Ż� �!~���5� �K_�X�� ��/ �k�7�1%��o�_��p!�'5���>n^([u�=���������m}�*�����wF�?��/-�v�vh����-�S��ZB�K��"��2��j�R>5�������7O
o�
�S�[� ���)�W�+��
�D��e���q@��+n+��CwN~���0���*&�5��ϯ]�$ w�yuܳMY$� �q��@-X5dl9��#�W�0��a�%���k�R��X��F�̓��T[��ʹ#[�F�Sܽ�l��H��tr��8��xӃ�\�g�tb�{��#�'�@�;��I ��-����� E�h8��0
˅C��V���qx''�F��[9RxB�:�zb��}�b���Ё���t ;� >> /SA true /GSa 3 0 R 289.439999 0] /Filter /FlateDecode Testosterone Topical Gel, 1.62% CIII Contains 20.25 mg of testosterone in 1.25 grams of gel per unit dose. 19 0 obj The recommended starting dose of Testosterone Topical Solution is 60 mg of testosterone (2 pump actuations) applied once daily. endobj [0 /XYZ 43.6799999 >> /CreationDate (D:20200416165259-04'00') /F6 6 0 R 4 0 obj /F7 7 0 R Starting Testosterone Topical Solution, 30 mg/1.5 mL dose is 60 mg of testosterone (1 pump actuation of 30 mg of testosterone to each axilla), applied once daily, at the same time each morning.